Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor Stock

Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor Stock

Goldman Sachs notes that the equal-weight S&P index tends to underperform before reversing trends. Historical data shows the index lagged behind the market weight during the Dot Com bubble but later outperformed by 7 percentage points.

Read More

Did you find this insightful?